OTL
ABMD

Oak Thistle LLC’s Abiomed Inc ABMD Stock Holding History

Oak Thistle LLC’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,361
Closed -$334K – 241
2022
Q3 		$334K Buy
+1,361
New +$368K 1.2% 17

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Oak Thistle LLC's ABMD Position: Q4 2022 in Review

Oak Thistle LLC sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,361 shares — an estimated $334K sold.

Oak Thistle LLC first reported a position in ABMD in Q3 2022 and held it in 1 quarter. The position peaked at $334K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Oak Thistle LLC reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Oak Thistle LLC sold 1,361 Abiomed Inc shares in Q4 2022, an estimated $334K.
  • Oak Thistle LLC first reported a position in Abiomed Inc in Q3 2022 and held it in 1 quarter.
  • Oak Thistle LLC's Abiomed Inc position peaked at $334K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Oak Thistle LLC's 13F filing for Q4 2022, filed 7 Feb 2023.